MDxHealth (MDXH) Convertible Debt (2021 - 2025)

MDxHealth has disclosed Convertible Debt across 5 years of filings, most recently posting $136.2 million for Q2 2025.

• Convertible Debt for Q2 2025 came in at $136.2 million, up 1.72% year-over-year; the trailing twelve-month figure through Jun 2025 was $136.2 million (up 1.72% YoY), and the FY2025 annual result was $136.2 million, changed N/A from the prior year.
• Convertible Debt came in at $136.2 million for Q2 2025 at MDxHealth, roughly flat from $135.9 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $136.2 million in Q2 2025 to a low of $25.4 million in Q4 2021.
• The 5-year median for Convertible Debt is $113.8 million (2023), against an average of $98.9 million.
• Across the five-year window, Convertible Debt jumped 319.02% in 2023 and gained 1.72% in 2025, its largest moves.
• MDxHealth's Convertible Debt stood at $25.4 million in 2021, then jumped by 316.05% to $105.8 million in 2022, then gained by 9.82% to $116.2 million in 2023, then rose by 16.94% to $135.9 million in 2024, then rose by 0.23% to $136.2 million in 2025.
• The last three Convertible Debt figures came in at $136.2 million (Q2 2025), $135.9 million (Q4 2024), and $133.9 million (Q2 2024), per Business Quant data.